This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Neurological complications of COVID-19 (confirmed or suspected)

Investigators
Dr Ian Galea, University of Southampton
Dr Rachel Kneen, University of Liverpool
Dr Benedict Michael, University of Liverpool
Prof Sarah Pett, UCL
Dr Rhys Thomas, Newcastle University



Contact point: info@coronerve.com    www.coronerve.com

To report a case click here

 

Purpose

We are looking to collate the neurological complication of COVID-19.

The COVID-19 pandemic is an evolving national emergency in which a significant proportion of the population are expected to be infected. The experience of past pandemics, notably influenza subtype H1N1 in 1918 and 2009, suggests that neurological complications may occur. Though the proportion may be small, given the large number of infections the collective burden may be large.

 

Methods

The reporting neurologist will be sent a short case reporting form. Given the unprecedented strain the NHS is currently facing, this form has been kept purposely brief so as not to add to the workload of busy clinicians and staff-depleted teams, and is essentially a screening document. A minimum of information required to later identify the patient is requested, encrypted via a scrambling algorithm. Since no openly identifiable information is shared, consent is not required at this point. A similar strategy is already in use by the UK Renal Registry, for example.

At a later point, the local clinical research team linked to the reporting neurologist may be contacted and asked to either consent the patient or obtain assent from their significant other, using approved forms supplied by the central study team. Once consented, clinical details such as demographics, past medical history, symptoms, signs, test results, treatment, and progress will be gathered from the reporting neurologist or their team using a standardised case report form.

We have also partnered with the BPNA to identify cases under the age of 18y, the BNPA to identify neuropsychiatric complications, BASP to ensure we are notified of acute cerebrovascular presentations, and NACCS so that people primarily managed by neuro-intensivists are reported.


Contact Us

Association of British Neurologists
Ormond House
27 Boswell Street
London
WC1N 3JZ

Telephone: +44 (0)20 7405 4060
Email: info@abn.org.uk

Registered Charity No. 1077893
Company No. 3816842

Follow Us